That creates a lot of interest in Mr Burrell's tawdry tales, far outweighing the merits of their content.
Only the year-end sums will tell if this wave of fiscal belligerence has won benefits outweighing the costs.
Caucasians filled 77 percent of all roles, far outweighing their respective population size in the metro and tri-state areas.
This, she said, could well be outweighing the negative effects of radioactive exposure.
At the moment, all 11 governors can vote, outweighing the six-member executive board.
Employment in services rose strongly, outweighing falls in construction and manufacturing.
The new normal is more of the same: a mixed bag of positive and negative news and data, with the negative outweighing the positive on balance.
FORBES: For Businesses, A Misty-Eyed View Of Economy As Sentiment Worsens
The authors of Teenagers and Technology also found that parental fears about teenage time-wasting on social network sites were often unfounded with the benefits using digital technologies outweighing perceived risks.
My question to us all picking up and using the latest technological advances is: at what point do we weigh the pros and cons for the risk outweighing the benefits?
FORBES: How Facial Recognition Technology Can Be Used To Get Your Social Security Number
Some indicators pointed to a gender disparity in the field, with women outweighing men by a 3:1 margin overall, but reducing to less than half in senior executive positions, with 49.7% of senior management jobs accounted for by men.
FORBES: Who Works In CSR? A New Report Defines The Profession
EGCs and underwriters view the benefit of additional information as outweighing the cost, as it allows more thorough discussion and analysis of trends and uncertainties, as well as more meaningful due diligence to make sure the disclosure overall is fair and accurate.
FORBES: On Its One-Year Anniversary, Two Cheers For The JOBS Act
Too much bleeding could be seen as outweighing efficacy, and newer pills could steal some of Avastin's thunder. (The drug must be given intravenously.) Data for PTK-787, a pill from Novartis (nyse: NVS - news - people ) and Germany's Schering (nyse: SHR - news - people ), which also hits VEGF, will be presented at ASCO.
应用推荐